INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,002,540 | +45.5% | 594,160 | +21.6% | 0.04% | +53.8% |
| Q2 2023 | $10,313,089 | +32.4% | 488,772 | +7.0% | 0.03% | +18.2% |
| Q1 2023 | $7,787,076 | -14.3% | 456,720 | +0.4% | 0.02% | -24.1% |
| Q4 2022 | $9,091,619 | +42.3% | 455,036 | +53.4% | 0.03% | +31.8% |
| Q3 2022 | $6,389,000 | +878.4% | 296,620 | +967.0% | 0.02% | +1000.0% |
| Q1 2022 | $653,000 | -12.8% | 27,800 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $749,000 | -91.9% | 27,500 | -91.8% | 0.00% | -90.5% |
| Q3 2021 | $9,232,000 | +18.8% | 335,209 | +22.7% | 0.02% | +16.7% |
| Q2 2021 | $7,773,000 | +1.6% | 273,135 | +21.6% | 0.02% | -10.0% |
| Q1 2021 | $7,648,000 | +1584.6% | 224,547 | +1546.7% | 0.02% | +1900.0% |
| Q4 2020 | $454,000 | -93.5% | 13,636 | -93.7% | 0.00% | -96.0% |
| Q3 2020 | $6,941,000 | +59.2% | 215,962 | +36.4% | 0.02% | +13.6% |
| Q2 2020 | $4,359,000 | +484.3% | 158,291 | +240.0% | 0.02% | +266.7% |
| Q1 2020 | $746,000 | -39.7% | 46,555 | -10.1% | 0.01% | +50.0% |
| Q4 2019 | $1,237,000 | -71.1% | 51,796 | -78.7% | 0.00% | -71.4% |
| Q3 2019 | $4,285,000 | -63.7% | 242,937 | -47.4% | 0.01% | -65.0% |
| Q2 2019 | $11,817,000 | +339.5% | 461,611 | +399.1% | 0.04% | +344.4% |
| Q1 2019 | $2,689,000 | +493.6% | 92,491 | +168.0% | 0.01% | +350.0% |
| Q4 2018 | $453,000 | -41.8% | 34,512 | -10.3% | 0.00% | 0.0% |
| Q3 2018 | $778,000 | +244.2% | 38,479 | +303.3% | 0.00% | +100.0% |
| Q2 2018 | $226,000 | -89.5% | 9,542 | -90.0% | 0.00% | -85.7% |
| Q1 2018 | $2,159,000 | -40.4% | 95,885 | -17.4% | 0.01% | -41.7% |
| Q4 2017 | $3,621,000 | -29.3% | 116,127 | -29.3% | 0.01% | -33.3% |
| Q3 2017 | $5,123,000 | +1220.4% | 164,141 | +625.0% | 0.02% | +1700.0% |
| Q2 2017 | $388,000 | +78.8% | 22,639 | +63.2% | 0.00% | 0.0% |
| Q3 2013 | $217,000 | -86.8% | 13,873 | -89.9% | 0.00% | -91.7% |
| Q2 2013 | $1,650,000 | – | 137,942 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |